AI
Czech Hospitals Are Already Using AI. Governance Is the Next Problem
Prague — Artificial intelligence is moving out of the laboratory and into ordinary Czech hospital workflows, with radiology leading the shift and governance becoming the next major constraint.
By Petra Nováková · Economist & Contributing Author · Published
A national survey published by the Czech Ministry of Health in February 2026 found that artificial intelligence is increasingly becoming a normal part of Czech healthcare. Radiology was the most advanced area, but hospitals also reported growing use of AI in administration, diagnostics and clinical decision support.
Those numbers make healthcare one of the clearest examples of the gap between the public AI debate and what is already happening inside Czech organisations, a gap this publication has tracked across the wider enterprise base. This is no longer primarily a pilot story.
Radiology was the obvious starting point
Healthcare is particularly suited to narrow AI systems. Radiology generates large volumes of structured imaging data, diagnostic workflows are relatively repeatable and models can be used to flag abnormalities without necessarily replacing the clinician making the final decision. That makes the technology easier to integrate than a general-purpose AI system expected to make broad medical judgements.
The result is visible in the survey data. Radiology is substantially ahead of the healthcare sector overall. But adoption is beginning to spread into administrative and clinical workflows where the value proposition is different: reducing documentation, prioritising cases, supporting decision-making and allowing scarce medical staff to spend less time on repetitive work.
For a healthcare system facing demographic pressure and workforce constraints, that productivity argument is difficult to ignore.
The bottleneck is becoming governance
The interesting development in 2026 is that Czech health policy is starting to catch up with deployment. In July, the Ministry of Health signed a cooperation memorandum with the Czech AI Association and medical institutions aimed at establishing a framework for certified AI, clinical guidance, pilot projects, education and quality standards.
The direction is sensible. Hospitals do not simply need more AI products. They need a repeatable way to decide which products can be trusted. That includes clinical validation, data quality, cybersecurity, responsibility when recommendations are wrong and clarity over where human oversight remains mandatory.
The sector is moving from experimentation to institutionalisation — the same transition the national AI strategy has been graded against.
Free newsletter
The Czech Business Brief
One email a week on Czech AI, consulting and startup capital: what moved, who paid for it, and what it means. No hype.
Czech healthtech now has a domestic proving ground
There is also a business angle. A healthcare system actively experimenting with AI creates an unusually valuable environment for Czech healthtech companies and university spinouts.
The strongest companies will not necessarily be those with the most impressive model in a laboratory. They will be the ones that can survive procurement, integrate into existing hospital systems, demonstrate measurable clinical value and satisfy increasingly formal governance standards. That is a much higher bar, but it also creates defensibility.
The Czech Republic has spent years debating how to turn a strong technical talent base into commercially significant AI companies. Healthcare may become one of the places where that transition happens. The adoption numbers suggest the customers are already there.